Last reviewed · How we verify
Metformin gel, 30%
At a glance
| Generic name | Metformin gel, 30% |
|---|---|
| Sponsor | Jinnah Postgraduate Medical Centre |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Comparison of Efficacy of Metformin Gel 30% vs Triple Combination Cream (Hydroquinone 4%, Flucinolone Acetonide 0.01%, Tretinoin 0.025%) in Treatment of Melasma in Tertiary Care Hospital Karachi (NA)
- Platelet Rich Fibrin With 1% Metformin Gel for Treatment of Intrabony Defects (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Metformin gel, 30% CI brief — competitive landscape report
- Metformin gel, 30% updates RSS · CI watch RSS
- Jinnah Postgraduate Medical Centre portfolio CI